Salvatore Calabrese

Chief Financial Officer, Gain Therapeutics, Inc.

Companies

Gain Therapeutics, Inc.Chief financial officer Mar 29, 2021 to Mar 27, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Gain Therapeutics, Inc. GANX3,000 shares²$3.7K at $1.25May 19, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 19, 2022Bought 3,000 shares at $2.70 of Gain Therapeutics, Inc.²
May 19, 2022Bought 3,000 shares at $8,100.00 of Gain Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGain Therapeutics, Inc., Chief financial officer
2
SEC EDGARGain Therapeutics, Inc. shares after the filing of May 19, 2022
3
SEC EDGARForm 4 filed May 19, 2022